1988
DOI: 10.1136/jnnp.51.2.197
|View full text |Cite
|
Sign up to set email alerts
|

Neurological correlations of ejaculation and testicular size in men with a complete spinal cord section.

Abstract: SUMMARY This study was of 135 patients with a complete spinal cord section suffered from loss of ejaculation. The spinal cord injuries were classified following the upper and the lower limits of the lesion. The volume of the testes of the patients and of 13 normal control subjects were measured. Physostigmine allowed 75 patients to ejaculate and 15 of them procreated. The possibility of ejaculation after physostigmine mainly depended on the integrity of the T12-L2 metamers. The testicular volume was significan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
1

Year Published

1992
1992
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(13 citation statements)
references
References 22 publications
(9 reference statements)
0
12
0
1
Order By: Relevance
“…For treatment of patients with AE caused by SCI, the parasympathomimetics physostigmine and neostigmine had been used with limited success (Kamischke & Nieschlag, 1999b). Therefore, because of their side effects profile and lower success rate compared with electrovibration stimulation and electroejaculation, neostigmine and physostigmine should not be considered as treatment of first choice in the treatment of AE in patients with SCI (Chapelle et al, 1988;Linsenmeyer & Perkash, 1991;Kamischke & Nieschlag, 2002).…”
Section: Known Medical Causes Of Male Infertilitymentioning
confidence: 99%
“…For treatment of patients with AE caused by SCI, the parasympathomimetics physostigmine and neostigmine had been used with limited success (Kamischke & Nieschlag, 1999b). Therefore, because of their side effects profile and lower success rate compared with electrovibration stimulation and electroejaculation, neostigmine and physostigmine should not be considered as treatment of first choice in the treatment of AE in patients with SCI (Chapelle et al, 1988;Linsenmeyer & Perkash, 1991;Kamischke & Nieschlag, 2002).…”
Section: Known Medical Causes Of Male Infertilitymentioning
confidence: 99%
“…The authors observed that there was less likelihood of ejaculation if the lesion was between T10 and L4. Other investigators employed either subcutaneous injection of physostigmine (Chapelle et al, 1988) or intrathecal injection of neostigmine (Piera, 1973) (Table 1). However, the latter treatments were abandoned by most physicians because of a high incidence of severe side effects such as AD.…”
Section: Sperm Recoverymentioning
confidence: 99%
“…However, neostigmine has to be judged obsolete because of severe side‐effects. Although physostigmine in SCI patients is significantly more effective (56% overall success) than the alpha agonists in non‐SCI patients, physostigmine also has potentially severe side‐effects and, with one exception (Chapelle et al ., 1988), has only been applied in a clinical setting. To reduce side‐effects physostigmine (1–2 mg s.c.) should only be applied after pre‐treatment with 20–40 mg butylhyocine bromide and under careful monitoring of signs of autonomic dysreflexia (Linsenmeyer & Perkash, 1991) in SCI patients.…”
Section: Treatment Of Aementioning
confidence: 99%